Biochemical diagnosis of neurodegenerative diseases gets closer

The Lancet Neurology

Volumn 10, Issue 3, 2011, Pages 203-205

  Parnetti, Lucilla ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER;

BIOCHEMISTRY; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; EARLY DIAGNOSIS; HUMAN; LETTER; MOTOR DYSFUNCTION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FOLDING; SHY DRAGER SYNDROME;

BIOLOGICAL MARKERS; HUMANS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 79951722837     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70019-9     Document Type: Letter

References (9)

1. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992, 42:1142-1146.
2. Blennow K, Hampel H, Weiner M, Zetterberg H Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 2010, 6:131-144.
3. Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 2011, published online Feb 14, 2011. 10.1016/S1474-4422(11)70014-X.
4. El-Agnaf OM, Salem SA, Paleologou KE, et al. α-Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J 2003, 17:1945-1947.
5. Tokuda T, Salem SA, Allsop D, et al. Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease. Biochem Biophys Res Commun 2006, 349:162-166.
6. Mollenhauer B, El-Agnaf OMA, Marcus K, Trenkwalder C, Schlossmacher MG Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies. Biomarkers Med 2010, 4:683-699.
7. Parnetti L, Chiasserini D, Bellomo G, et al. Cerebrospinal fluid tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. Mov Disord (in press).
8. Paleologou KE, Kragh CL, Mann DM, et al. Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 2009, 132:1093-1101.
9. Tokuda T, Qureshi MM, Ardah MT, et al. Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 2010, 75:1766-1772.